Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Cel-Sci Corporation ($0.001 Par Value) logo

Cel-Sci Corporation ($0.001 Par Value)

Sector: Healthcare   

Industry: Biotechnology

2.45
 
USD
  
-0.15
  
(-5.77%)
Optionable: Yes  Market Cap: 117 M  90-day average vol: 1,206,630

Previous close: 2.6  Open: 2.6  Bid: 2.45  Ask: 2.5
52 week range    
1.04   
   3.33
Peers   
CASI / 
CRIS / 
BCRX / 
AMGN / 
CYTR / 
TEVA / 
JNJ / 
XNCR / 
EBS / 
Last updated: Wednesday 29th November 2023

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

AMGN

0.0347129 B23.4223.53

BCRX

3 B-12.216.38

CASI

0 B-1.90.7079

CRIS

0 B-7.33.36

CYTR

0 B-3.30.4752

EBS

3 B11.145.67

JNJ

0.0247450 B22.1171.06

TEVA

TTNP

0 B-21.26

XNCR

2 B-343.732.54
Financials

CVM Income Statement

Annual
Sep-13Sep-14Sep-15Sep-16Sep-17Sep-18Sep-19Sep-20Sep-21Sep-22
AccruedPreferredStockDividends59531.01 M63768.014368.021734.0350861.0929122.0
AcquiredInProcessRnD-760603.0-21734.0
Amortization-88207.0-42785.0-40471.0-38000.0-40000.0-75000.0-45000.0-53000.0-52000.0
Amortization of intangibles-88207.0-42785.0-40471.0-38000.0-40000.0-75000.0-45000.0-53000.0-52000.0
Basic EPS total-7.5-12.0-10.5-59.25-1.83-1.87-0.71-0.82-0.9-0.87
Basic weighted shares outstanding1 M2 M3 M194648.08 M17 M31 M74 M41 M43 M
Depreciation364124.0231752.0-680000.0-626000.0-593000.0-575000.0-588000.0-389000.0-447000.0-2 M
Depreciation unreconciled364124.0231752.0206750.0-588000.0
DepreciationAndAmortization364124.0231752.0-680000.0-626000.0-593000.0-575000.0-588000.0-389000.0-447000.0-2 M
Diluted EPS total-16.5-12.25-10.5-59.25-1.91-1.87-0.71-0.82-0.9-0.87
Diluted normalized net income/share-0.93-0.87
Diluted weighted shares outstanding555814.02 M4 M214865.08 M17 M31 M37 M41 M43 M
Earnings from equity interest-694858.0
EarningsFromEquityInterestNetOfTax-694858.0
GainOnSaleOfBusiness11 M248767.0-760603.0-349078.0
GainOnSaleOfPPE-694858.0
GainOnSaleOfSecurity11 M248767.0-805753.0-1 M6000.0
GeneralAndAdministrativeExpense7 M11 M14 M6 M6 M6 M8 M12 M13 M11 M
Gross operating profit159583.0248767.0-9 M
Income before tax-9 M-27 M-35 M-26 M-14 M-32 M-22 M-30 M-36 M-37 M
Interest income117086.0122854.0-2 M-2 M-4 M-4 M-2 M
InterestExpenseNonOperating170423.0163774.0129985.0-1 M
MiscOtherSpecialCharges159583.0264033.0319536.0285055.011 M-2 M1 M679278.02 M76355.0
Net income from total operations-9 M-27 M-35 M-26 M-14 M-32 M-22 M-30 M-36 M-37 M
NetIncomeCommonStockholders-9 M-28 M-35 M-26 M-14 M-32 M-22 M-30 M-37 M-38 M
NetIncomeContinuousOperations-9 M-27 M-35 M-26 M-14 M-32 M-22 M-30 M-36 M-37 M
NetNonOperatingInterestIncomeExpense-53337.0-40920.0-2 M-2 M-4 M-4 M-2 M1 M
NetOperatingInterestIncomeExpense-2 M-2 M-2 M-1 M-1 M-1 M
Operating income-20 M-28 M-33 M-24 M-21 M-25 M-21 M-30 M-36 M-36 M
Operating income before depreciation (EBITDA)-9 M-27 M-35 M-25 M-13 M-29 M-22 M-29 M-34 M-33 M
OperatingExpense-20 M-28 M-33 M-24 M-21 M-17 M-21 M-30 M-36 M-36 M
Other income net-11 M-264033.0-319536.0-285055.0-11 M2 M-1 M-330200.0-982308.0-76355.0
OtherGandA7 M11 M14 M6 M6 M6 M8 M12 M13 M11 M
OtherImpairmentOfCapitalAssets-22628.0-1182.0
OtherOperatingExpenses-20 M-28 M-33 M-24 M-17 M-21 M
OtherunderPreferredStockDividend59531.01 M63768.014368.021734.0350861.0929122.0
PreferredStockDividends59531.01 M63768.014368.021734.0350861.0929122.0
RealizedCapitalGain14 M
RentAndLandingFees7 M11 M14 M6 M6 M6 M8 M12 M13 M11 M
Research & development expense13 M17 M19 M17 M16 M11 M13 M18 M23 M25 M
ResearchExpense13 M17 M19 M17 M16 M11 M13 M18 M23 M25 M
SalariesAndWages-3 M-4 M-5 M-2 M-1 M-476556.0-4 M-10 M-14 M-11 M
Selling Gen & administrative expense7 M11 M14 M6 M6 M6 M8 M12 M13 M11 M
Special income/charges-760603.0-21734.0
Total Income available for interest expense (EBIT)-9 M-27 M-35 M-26 M-14 M-32 M-22 M-31 M-36 M-37 M
Total common shares outstanding2 M4 M5 M301959.013 M28 M35 M40 M43 M44 M
Total net income-9 M-27 M-35 M-26 M-14 M-32 M-22 M-30 M-36 M-37 M
Total ordinary shares47 M47 M47 M47 M47 M47 M47 M47 M47 M47 M
Total revenues159583.0248767.0-9 M
TotalExpenses-20 M-28 M-33 M-24 M-21 M-17 M-21 M-30 M-36 M-36 M
TotalRevenue159583.0248767.0-9 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today